A new version of the national directive is available to supplement the European guidelines (v3) for the management of clinical trials during the coronavirus pandemic.
News FAMHP
There are 65 result(s) found based on your search criteria
31-40 from 65 result(s)
Coronavirus: delivery of medicinal products to ambulatory patients’ homes by the authorised hospital
On an exceptional basis during the COVID-19 pandemic, the FAMHP is authorising hospital pharmacies to organise deliveries of medicinal products directly to the homes of ambulatory patients who are unable to go to the hospital.
Identity theft: attempts to order medical equipment in the FAMHP’s name
The FAMHP has been contacted by several companies from which the FAMHP has supposedly ordered medical or laboratory equipment. This is a case of identity theft, whereby FAMHP information is being misappropriated to steal equipment.
Coronavirus: circular for care institutions on the (outsourcing of the) manufacture and reprocessing of medical devices and their accessories
In order to combat shortages of medical devices, care institutions have proceeded to manufacture medical devices and their accessories or to reprocess used medical devices. The FAMHP defines the modalities by means of a circular in order to offer more options to care institutions.
Coronavirus: Belgian directive for the reuse of surgical masks and FFP2/FFP3 masks in the context of the COVID-19 epidemic
A national guideline is available for the reprocessing of surgical masks and FFP2/FFP3 masks which allows reuse by cleaning, disinfecting or sterilising.
Coronavirus: guidelines for checking the compliance and suitability of certain surgical face masks
The FAMHP issues guidelines for checking the compliance and suitability of surgical face masks The guidelines are for companies not producing in accordance with European standards and for healthcare establishments and authorities ordering the masks.
Coronavirus: what medicinal products are used in the fight against COVID-19?
In the fight against the new coronavirus, doctors are using medicinal products that were initially developed to treat other pathologies. The FAMHP summarises the actions and measures that have been taken.
Coronavirus: no shortage in medication supply, FAMHP closely monitoring the situation
Following the coronavirus epidemic (COVID-19), experts at FAMHP are actively monitoring the potential impact on the availability of medication and medical devices in Belgium. The FAMHP is also supporting the European Medicines Agency (EMA) in developing COVID-19 vaccines.
Jean-Michel Dogné, pharmacovigilance expert at the FAMHP, is appointed member of the World Health Organization's Global Advisory Committee on Vaccine Safety
Jean-Michel Dogné has been putting his expertise at the service of the FAMHP for many years. The Belgian expertise in vaccines is recognised worldwide with his recent appointment as a member of the Global Advisory Committee on Vaccine Safety (GACVS) of the World Health Organisation (WHO).
The FAMHP is extending its network of European partnerships
In its capacity as the competent national authority, the FAMHP is actively engaged at a European level. In the context of its international activities, the agency keeps developing its network of European partnerships.